PEMGX
Price
$40.07
Change
-$0.55 (-1.35%)
Updated
Aug 20 closing price
Net Assets
23.39B
PHSKX
Price
$37.17
Change
-$0.33 (-0.88%)
Updated
Aug 20 closing price
Net Assets
372.76M
Interact to see
Advertisement

PEMGX vs PHSKX

PEMGX vs PHSKX Comparison Chart in %
View a ticker or compare two or three
VS
PEMGX vs. PHSKX commentary
Aug 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Hold and PHSKX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 23.4B vs. PHSKX (373M). PEMGX (0.00) and PHSKX (0.00) have matching dividends . PEMGX was incepted earlier than PHSKX: PEMGX (21 years) vs PHSKX (51 years). PHSKX (1.26) is less costly to investors than PEMGX (0.90). PHSKX is a more actively managed with annual turnover of: 27.00 vs. PEMGX (13.70). PEMGX (6%) and PHSKX (6%) have equivalent initial investment costs. PEMGX has a lower initial minimum investment than PHSKX: PEMGX (1000) vs PHSKX (2500). PEMGX annual gain was more profitable for investors over the last year : -10.23 vs. PHSKX (-37.00). PEMGX return over 5 years is better than : -0.49 vs. PHSKX (-47.00).
PEMGXPHSKXPEMGX / PHSKX
Total Expense Ratio0.901.2671%
Annual Report Gross Expense Ratio0.901.2671%
Fund Existence21 years51 years-
Gain YTD-0.270-3.9457%
Front Load6%6%100%
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B373M6,273%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.23-37.0028%
Returns for 3 years20.46-26.20-78%
Returns for 5 years-0.49-47.001%
Returns for 10 years81.9360.53135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUPH16.170.87
+5.69%
Aurinia Pharmaceuticals
CYTK77.741.64
+2.16%
Cytokinetics
SGU12.610.08
+0.64%
Star Group LP
BGSF5.53-0.02
-0.36%
BGSF
RFAIU10.50-0.53
-4.81%
RF Acquisition Corp II